When you look at smaller public companies in the therapeutics industry. Most are over hyped and over valued. Most do not provide returns for their investors. 

But every now and then you come across a company that has potential to climb!!! That is CVKD! This company is literally in PHASE 3 and is doing collaborative work with ABBOTT!!! What?? That's insane. It's one of the few phase 3 companies that's under $100m market cap! This company could see significant gains in the near future!! Put this company on your Rader IMMEDIATELY!!